International Patent: MHC-II EXPRESSION ON BLADDER CANCER CELLS AS A PREDICTIVE MARKER FOR RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY

GENEVA, July 18 -- DANA-FARBER CANCER INSTITUTE, INC. filed a patent application (IB2026/050245) for “MHC-II EXPRESSION ON BLADDER CANCER CELLS AS A PREDICTIVE MARKER FOR RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY”. With publication no. WO/2026/150372, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/6886

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....